All posts tagged: HPV

Allu Arjun Fans Launch HPV Vaccine Awareness Drive Ahead of His Birthday

Allu Arjun Fans Launch HPV Vaccine Awareness Drive Ahead of His Birthday

The Allu Arjun Fans Association, which was recently formalised, has launched a new initiative to support HPV vaccination awareness. Inspired by the Pushpa 2 actor’s message of carrying out “one good deed every year,” the group has taken up this social cause ahead of the star’s birthday on April 8. The association is planning a series of awareness programmes that will run throughout the year to educate people about the importance of the vaccine. HPV vaccine fights cervical cancer Health experts state that the HPV vaccine is crucial for young girls, as it offers strong protection against cervical cancer. Girls and women between the ages of 9 and 26 can receive the vaccine free of cost at government hospitals under the central government’s “Swasth Nari Viksit Bharat” programme. The fan association aims to ensure that every eligible individual is aware of this life-saving opportunity. This is not the first time the actor has been associated with charitable initiatives. The Ala Vaikunthapurramuloo star has a history of helping those in need. In September 2024, he donated …

Why HPV DNA testing must anchor India’s cervical cancer elimination strategy

Why HPV DNA testing must anchor India’s cervical cancer elimination strategy

In India, every few minutes, a mother, a daughter, a sister or a wife loses her life to cervical cancer. These deaths are completely preventable. Cervical cancer is one of the few cancers we already know how to defeat. When detected early, it can be cured in more than 90% of cases. And, more importantly, it can also be prevented. Yet, it is the second most common cancer among Indian women, and cases in India account for the second highest burden in the world. The challenge lies not in the absence of solutions, but in early and equitable access to them. Today, two-thirds of women in India are diagnosed only after the disease has spread, and when survival rates drop to around 46%. Cervical cancer (Freepik) India has made commendable progress in building the foundation for cervical cancer screening through the National Programme for Non-Communicable Diseases, NP NCD under the National Health Mission. Yet, despite years of effort, only 40% of eligible women have ever been screened. In some states, the rate is still below …

Nearly 3 lakh girls vaccinated in nationwide HPV drive within fortnight

Nearly 3 lakh girls vaccinated in nationwide HPV drive within fortnight

In a powerful step towards safeguarding the health and future of young girls, several states, including Madhya Pradesh, Andhra Pradesh, Tamil Nadu, Gujarat, Odisha, and Mizoram, are leading from the front in the nationwide HPV vaccination campaign. Within just a fortnight of its launch, nearly 3 lakh girls aged 14 years have already been vaccinated, marking an encouraging start to this critical public health initiative, a health ministry official informed, reported ANI.  According to experts Human Papillomavirus (HPV) vaccine plays a vital role in preventing cervical cancer, one of the most common cancers affecting women. The enthusiastic participation seen so far reflects growing awareness among parents, schools, and communities about the importance of early protection. HPV Vaccination drive gains strong response despite ongoing exams According to ANI, the campaign has been strategically rolled out during the academic period, and while examinations are currently underway in many regions, the response has remained strong. With the conclusion of the exam season approaching, the momentum of the vaccination drive is expected to accelerate significantly, enabling wider coverage and …

Centre Plans School-Led Push To Reach Girls For HPV Vaccine, Education Ministry To Ask Boards | India News

Centre Plans School-Led Push To Reach Girls For HPV Vaccine, Education Ministry To Ask Boards | India News

Last Updated:March 12, 2026, 07:00 IST Schools will be asked to help identify eligible beneficiaries and sensitise parents about cervical cancer prevention and the benefits of vaccination The HPV vaccine is a powerhouse and targets the human papillomavirus, which causes nearly all cervical cancers. (Image for representation: AP) The education ministry is set to rope in school boards across the country to actively promote the HPV vaccination campaign for adolescent girls. News18 has learnt that the Centre is preparing to use schools as a key platform to reach out to girls, who are eligible for the jab against cervical cancer. According to operational guidelines prepared for the rollout of the human papillomavirus (HPV) vaccination programme, the ministry of education will work with national and state school boards to raise awareness on the prevention of cervical cancer and help mobilise girls aged 14 to get the vaccine. The guidelines state that the ministry will issue directions to key school boards and education networks to support the campaign. These include CBSE, ICSE, Kendriya Vidyalaya Sangathan and Navodaya …

Centre Plans School-Led Push To Reach Girls For HPV Vaccine, Education Ministry To Ask Boards | India News

HPV Vaccine Misinformation Surges As India Begins National Rollout: Here’s What You Should Know | India News

Last Updated:March 07, 2026, 10:28 IST WHO’s vaccine safety advisory committee and multiple large studies have found no credible evidence linking HPV vaccination to infertility. The HPV vaccine is a powerhouse. It targets the human papillomavirus, which causes nearly all cervical cancers. (Representational image/AP) India’s long-awaited national initiative to vaccinate adolescent girls against the Human Papilloma Virus (HPV) has been widely praised as a major move toward preventing cervical cancer. However, as the campaign begins to roll out across the country, it has also sparked a surge of misinformation online, bringing back earlier fears and conspiracy theories about the vaccine’s safety. Viral Misinformation Several posts circulating on social media platforms claim that HPV vaccines could lead to infertility, lack sufficient safety data, or were associated with deaths during earlier trials conducted in India. In recent weeks, many of these claims have spread widely, fuelling concern among parents at a time when the government is preparing to expand one of the country’s most significant cancer-prevention efforts. According to health experts, much of the content circulating online …

PM Modi`s focus on preventive healthcare; HPV vaccination drive launched in J&K

PM Modi`s focus on preventive healthcare; HPV vaccination drive launched in J&K

In line with Prime Minister Narendra Modi`s commitment towards strengthening preventive healthcare for girls, the 90-day Human Papillomavirus (HPV) vaccination drive was launched in Jammu and Kashmir`s Bhaderwah on Tuesday. The 90-day Human Papillomavirus (HPV) vaccination drive commenced in Bhaderwah with its formal inauguration at the Sub-District Hospital Bhaderwah. The campaign was inaugurated by ADC Bhaderwah Sunil Kumar Butyal in the presence of Block Medical Officer Bhaderwah Dr Varsha Sharma. During the inaugural session, the first batch of 10 girls aged 14 years received the HPV vaccine. Health officials informed that girls in the age group of 14 to 15 years across Addational District Bhaderwah will benefit from the vaccination campaign aimed at preventing Human Papillomavirus (HPV) infection, a leading cause of cervical cancer. Speaking on the occasion, ADC Sunil Kumar Butyal emphasised the importance of preventive healthcare and urged parents to ensure their eligible daughters participate in the campaign. He lauded the efforts of the Health Department for spreading awareness and ensuring smooth implementation of the drive. Officials urged parents to actively participate and …

After wife’s cervical cancer treatment and Rs 30 lakh bill, a father turns to HPV vaccine to protect daughters | Health and Wellness News

After wife’s cervical cancer treatment and Rs 30 lakh bill, a father turns to HPV vaccine to protect daughters | Health and Wellness News

In the quiet moments between hospital visits and blood transfusions, 58 year-old Anil Singh finds himself thinking about the future of his two 20-year-old daughters. After watching his wife endure years of cervical cancer treatment, he is now determined to get them vaccinated against HPV, the human papilloma virus responsible for most cervical cancers. “Had this vaccine been available or had I known about it earlier, I would have ensured that my wife too, had a shot. Now doctors say that taking the HPV vaccine in your 40s can still provide benefits, specifically by protecting against high-risk HPV strains you have not yet been exposed to,” he says. While not routinely recommended for those over 26, the US Food and Drug Administration (FDA) has approved the Gardasil 9 vaccine for individuals up to age 45. Singh has had a long, exhausting and financially draining journey since 2018, when his wife, Baby Singh, now 53, first developed symptoms. It started with watery discharge, followed by bleeding. They consulted a local gynaecologist who recommended a biopsy when …

Centre Plans School-Led Push To Reach Girls For HPV Vaccine, Education Ministry To Ask Boards | India News

20 Years Of Data, Millions Vaccinated: What Science Says About HPV Vaccine Amid Social Media Myths | Explainers News

Last Updated:February 28, 2026, 16:17 IST Doctors say the answer lies not in viral forwards but in decades of scientific evidence, population studies and real-world data from countries that introduced vaccination years ago As misinformation circulates, some public figures and clinicians have taken to social media to counter it. (AP) As India rolls out its nationwide HPV vaccination campaign from Saturday, social media platforms are buzzing. Some posts amplify fears, questioning safety, fertility, dosage, and long-term effects. Others cite global data, research, and cancer reduction trends to defend the vaccine. So, who is right? What should parents believe? Doctors say the answer lies not in viral forwards but in decades of scientific evidence, large population studies and real-world data from countries that introduced HPV vaccination years ago. Before making any health decision, experts advise families to consult their doctors. But here’s what clinicians and published science currently show. What Doctors Say Medical experts told News18 that much of the current anxiety is “recycled misinformation” that has circulated globally for years. According to Neelam Mohan, senior …

Centre to launch nationwide HPV vaccination drive for 14-year-old girls

Centre to launch nationwide HPV vaccination drive for 14-year-old girls

In a major step towards eliminating preventable cancers among women, the Union government will soon launch a nationwide human papillomavirus (HPV) vaccination programme targeting girls aged 14 years, official sources said on Tuesday. The nationwide programme will target girls aged 14 years, an age at which the HPV vaccine offers maximum preventive benefit, well before potential exposure to the virus. In the open market, quadrivalent Gardasil-4 is a two-dose vaccine — each costing Rs 3927 — for girls below 15 years. This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever Disclaimer: We do not own any of the content, ideas, images, or text presented here. All rights belong to their respective owners. For more information and to view the original source, please visit the following link: Source link

Expert Panel Asks Serum Institute To Tighten HPV Vaccine Trial Before Testing On Women Of Childbearing Age | India News

Expert Panel Asks Serum Institute To Tighten HPV Vaccine Trial Before Testing On Women Of Childbearing Age | India News

Last Updated:November 07, 2025, 07:30 IST Committee seeks stronger trial design, urging SII to sharpen objectives and raise scientific standards for proving CERVAVAC’s non-inferiority to Merck’s Gardasil The panel wants the company to collect blood samples before giving the third vaccine dose. (Representational image) India’s expert committee on vaccines has asked the Serum Institute of India (SII) to revise its Phase III trial plan before moving ahead with tests of its cervical cancer vaccine in women of childbearing age. The vaccine is currently approved only for girls and young women aged 9 to 26 years. The committee has suggested key changes in the study design, including strengthening the trial’s objectives and tightening the scientific criteria for proving non-inferiority against Merck’s Gardasil. The Pune-based vaccine maker had presented the protocol of its proposed study titled, “A Phase-III, double-blind, randomized, active-controlled, multicentric clinical trial to evaluate the immunogenicity and safety of qHPV Vaccine (CERVAVAC) administered intramuscularly in women aged 27 to 45 Years as compared to Merck’s HPV 6/11/16/18 Vaccine (Gardasil).” According to the minutes of the …